Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, May 2026 and Jun 2026.
- Largest single sale: $11.6M (345,810 shares) of Teva Pharmaceutical Industries Ltd on Feb 26, 2026. Filing
- Last sale before this period: Jun 12, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | EVP, Chief Financial Officer | Feb 18, 2020 | Jun 16, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 11, 2026, Teva Pharmaceutical Industries Ltd: sold 106,563 shares for $3.6M, under a disclosed plan. 1 filing: 1
- May 14, 2026, Teva Pharmaceutical Industries Ltd: sold 153,251 shares for $5.5M, under a disclosed plan. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: 19,916 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: 56,763 shares vested. 1 filing: 1
- Mar 3, 2026, Teva Pharmaceutical Industries Ltd: 191,278 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.